Selected physiologic variables are weakly to moderately associated with 29 biomarkers of diet and nutrition, NHANES 2003-2006

Journal of Nutrition

Volumn 143, Issue 6, 2013, Pages

  Haynes, Bridgette M H ^a   Pfeiffer, Christine M ^a   Sternberg, Maya R ^a   Schleicher, Rosemary L ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CAROTENE; CREATININE; CYANOCOBALAMIN; FERRITIN; IODINE; IRON; MONOUNSATURATED FATTY ACID; PHYTOESTROGEN; POLYUNSATURATED FATTY ACID; RETINOL; XANTHOPHYLL;

ADULT; ARTICLE; BLOOD LEVEL; DIET; DIET RESTRICTION; ETHNICITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; KIDNEY FUNCTION; PREGNANCY; SMOKING; URINE LEVEL;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIET; DIETARY SUPPLEMENTS; FASTING; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION; IRON; KIDNEY DISEASES; LINEAR MODELS; MALE; MICRONUTRIENTS; MIDDLE AGED; NUTRITION SURVEYS; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; NUTRITIONAL STATUS; PHYTOESTROGENS; PREGNANCY; SMOKING; VITAMINS;

EID: 84878247322     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.112.172882     Document Type: Article

References (58)

1. Pfeiffer CM, Schleicher RL, Caldwell KL. Biochemical indices. In: Caballero B, editor. Enzyclopedia of human nutrition. 3rd ed, vol 1. Waltham (MA): Academic Press; 2013. p. 156-74.
2. Blanck HM, Bowman BA, Cooper GR, Myers GL, Miller DT. Laboratory issues: use of nutritional biomarkers. J Nutr. 2003;133 Suppl:888S-94S.
3. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington: National Academy Press; 1998.
4. Tomkins A. Assessing micronutrient status in the presence of inflammation. J Nutr. 2003;133 Suppl:1649S-55S.
5. Duncan A, Talwar D, McMillan DC, Stefanowica F, O'Reilly DStJ. Quantitative data on the magnitude of the systemic inflammatory response and its effect on micronutrient status based on plasma measurements. Am J Clin Nutr. 2012;95:64-71.
6. Calder PC, Ahluwalia N, Brouns F, Buetler T, Clement K, Cunningham K, Esposito K, Jönsson LS, Kolb H, Lansink M, et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr. 2011;106:S5-78.
7. Louw JA, Webeck A, Louw MEJ, Kotze TJ, Cooper R, Labadarios D. Blood vitamin concentrations during the acute-phase response. Crit Care Med. 1992;20:934-41.
8. Thurnham DI, McCabe GP, Northrop-Clewes CA, Nestel P. Effects of subclinical infection on plasma retinol concentrations and assessment of prevalence of vitaminAdeficiency:meta-analysis. Lancet. 2003;362:2052-8.
9. Stephensen CB, Gildengorin G. Serum retinol, the acute phase response, and the apparent misclassification of vitamin A status in the Third National Health and Nutrition Examination Survey. Am J Clin Nutr. 2000;72:1170-8.
10. Sakakeeny L, Roubenoff R, Obin M, Fontes JD, Benjamin EJ, Bujanover Y, Jacques PF, Selhub J. Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. adults. J Nutr. 2012;142:1280-5.
11. Morris MS, Sakakeeny L, Jacques PF, Picciano MF, Selhub J. Vitamin B-6 intake is inversely related to, and the requirement is affected by, inflammation status. J Nutr. 2010;140:103-10.
12. Friso S, Jacques PF, Wilson PWF, Rosenberg IH, Selhub J. Low circulating vitamin B6 is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation. 2001;103:2788-91.
13. Bates CJ, Pentieva KD, Prentice A, Mansoor MA, Finch S. Plasma pyridoxal phosphate and pyridoxic acid and their relationship to plasma homocysteine in a representative sample of British men and women aged 65 years and over. Br J Nutr. 1999;81:191-201.
14. Northrop-Clewes CA. The interpretation of indicators of iron status during an acute phase response. In: WHO/CDC. Assessing the iron status of populations: report of a joint World Health Organization/ Centers for Disease Control and Prevention technical consultation on the assessment of iron status at the population level. Geneva: World Health Organization; 2007 [cited 2013 Feb 24]. Available from: http:// www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/ 9789241596107.pdf.
15. Francis ME, Eggers PW, Hostetter TH, Briggs JP. Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int. 2004;66:303-12.
16. Jacques PF, Bostom AG, Wilson PWF, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr. 2001;73:613-21.
17. ord O, Vollset SE. The Hordaland Homocysteine study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr. 2006;136 Suppl:1731S-40S.
18. Bates CJ, Mansoor MA, van der Pols J, Prentice A, Cole TJ, Finch S. Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over. Eur J Clin Nutr. 1997;51: 691-7.
19. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Elevated serum methylmalonic acid concentrations are common among elderly Americans. J Nutr. 2002;132:2799-803.
20. Bates CJ, Schneede J, Mishra G, Prentice A, Mansoor MA. Relationship between methylmalonic acid, homocysteine, vitamin B12 intake and status and socio-economic indices, in a subset of participants in the British National Diet and Nutrition Survey of people aged 65y and over. Eur J Clin Nutr. 2003;57:349-57.
21. Vogiatzoglou A, Oulhaj A, Smith AD, Nurk E, Drevon CA, Ueland PM, Vollset SE, Tell GS, Refsum H. Determinants of plasma methylmalonic acid in a large population: implications for assessment of vitamin B12 status. Clin Chem. 2009;55:2198-206.
22. Hsu CY, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2002;13:504-10.
23. Hsu CY, McCulloch CE, Curhan GC. Iron status and hemoglobin level in chronic renal insufficiency. J Am Soc Nephrol. 2002;13:2783-6.
24. Pirtle CJ, Schoolwerth AC, Giles WH, Brown DW, Mokdad AH, Ford ES. State-specific trends in chronic kidney failure-United States, 1990- 2001. Morb Mortal Wkly Rep. 2004;53:918-20.
25. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999- 2010. JAMA. 2012;307:491-7.
26. U.S. Centers for Disease Control and Prevention. Crude and age-adjusted percentage of civilian, noninstitutionalized population with diagnosed diabetes, United States, 1980-2010 [cited 2013 Feb 24]. Available from: http://www.cdc.gov/diabetes/statistics/prev/national/figage.htm.
27. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc. Washington: National Academy Press; 2001.
28. U.S. Centers for Disease Control and Prevention. About the National Health and Nutrition Examination Survey [cited 2013 Feb 24]. Available from: http://www.cdc.gov/nchs/nhanes/about_nhanes.htm.
29. U.S. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey 2003-2004 lab methods [cited 2013 Feb 24]. Available from: http://www.cdc.gov/nchs/nhanes/nhanes2003- 2004/lab_methods_03_04.htm.
30. U.S. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey 2005-2006 lab methods [cited 2013 Feb 24]. Available from: http://www.cdc.gov/nchs/nhanes/nhanes2005- 2006/lab_methods_05_06.htm.
31. Sternberg MR, Schleicher RL, Pfeiffer CM. Regression modeling plan for 29 biochemical indicators of diet and nutrition measured in NHANES 2003-2006. J Nutr. 2013;143:948S-56S.
32. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80 Suppl:1678S-88S.
33. Ascherio A, Willett WC, Rimm EB, Giovannucci EL, Stampfer MJ. Dietary iron intake and risk of coronary disease among men. Circulation. 1994;89:969-74.
34. Tö rnqvist M, Fred C, Haglund J, Helleberg H, Paulsson B, Rydberg P. Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications. J Chromatogr B Analyt Technol Biomed Life Sci. 2002;778:279-308.
35. Shelnutt SR, Cimino CO, Wiggins PA, Badger TM. Urinary pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein. Cancer Epidemiol Biomarkers Prev. 2000;9:413-9.
36. Setchell KDR, Faughnan MS, Avades T, Zimmer-Nechemias L, Brown NM, Wolfe BE, Brashear WT, Desai P, Oldfield MF, et al. Comparing the pharmacokinetics of daidzein and genistein with the use of C-13-labeled tracers in premenopausal women. Am J Clin Nutr. 2003;77:411-9.
37. Kritchevsky SB, Bush AJ, Pahor M, Gross MD. Serum carotenoids and markers of inflammation in nonsmokers. Am J Epidemiol. 2000;152: 1065-71.
38. Ford ES, Liu S, Mannino DM, Giles WH, Smith SJ. C-reactive protein concentration and concentrations of blood vitamins, carotenoids, and selenium among United States adults. Eur J Clin Nutr. 2003;57:1157-63.
39. Gruber M, Chappell R, Millen A, LaRowe T, Moeller SM, Iannaccone A, Kritchevsky SB, Mares J. Correlates of serum lutein plus zeaxanthin: findings from the Third National Health and Nutrition Examination Survey. J Nutr. 2004;134:2387-94.
40. Chun OK, Chung SJ, Claycombe KJ, Song WO. Serum C-reactive protein concentrations are inversely associated with dietary flavonoid intake in US adults. J Nutr. 2008;138:753-60.
41. Pellegrini N, Valtuena S, Ardigo D, Brighenti F, Franzini L, Del Rio D, Scazzina F, Piatti PM, Zavaroni I. Intake of plant lignans matairesinol, secoisolariciresinol, pinoresinol, and lariciresinol in relation to vascular inflammation and endothelial dysfunction in middle age-elderly men and post-menopausal women living in Northern Italy. Nutr Metab Cardiovasc Dis. 2010;20:64-71.
42. Beard J. Indicators of the iron status of the population: free erythrocyte protoporphyrin and zinc protoporphyrin; serum and plasma iron, total iron binding capacity and transferrin saturation; and serum transferrin receptor. In: WHO/CDC. Assessing the iron status of populations: report of a joint World Health Organization/Centers for Disease Control and Prevention technical consultation on the assessment of iron status at the population level. Geneva: World Health Organization; 2007 [cited 2013 Feb 24]. Available from: http://www.who.int/nutrition/ publications/micronutrients/anaemia_iron_deficiency/ 9789241596107.pdf.
43. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res. 2008;47:348-80.
44. Ahmad I, Zhan M, Miller M. High prevalence of C-reactive protein elevation with normal triglycerides (100-149mg/dL): are triglyceride levels below 100mg/dL more optimal in coronary heart disease risk assessment? Am J Med Sci. 2005;329:173-7.
45. Arnadottir M, Hultberg B, Nilsson-Ehle P, Thysell H. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest. 1996;56:41-6.
46. Institute of Medicine, Food and Nutrition Board. Dietary reference intakes: vitamin C, vitamin E, selenium, and carotenoids. Washington: National Academy Press; 2000.
47. Milman N. Iron and pregnancy-a delicate balance. Ann Hematol. 2006;85:559-65.
48. Murphy MM, Molloy AM, Ueland PM, Fernandez-Ballart JD, Schneede J, Arija V, Scott JM. Longitudinal study of the effect of pregnancy on maternal and fetal cobalamin status in healthy women and their offspring. J Nutr. 2007;137:1863-7.
49. Milman N, Byg K-E, Bergholt T, Eriksen L, Hvas A-M. Cobalamin status during normal pregnancy and postpartum: a longitudinal study comprising 406 Danish women. Eur J Haematol. 2006;76:521-5.
50. Shields RC, Caric V, Hair M, Jones O, Wark L, McColl MD, Ramsay JE. Pregnancy-specific reference ranges for haematological variables in a Scottish population. J Obstet Gynaecol. 2011;31:286-9.
51. Johnston CS, Thompson LL. Vitamin C status of an outpatient population. J Am Coll Nutr. 1998;17:366-70.
52. Kang SS, Wong PW, Zhou JM, Cook HY. Total homocyst(e)ine in plasma and amniotic fluid of pregnant women. Metabolism. 1986;35:889-91.
53. Murphy MM, Scott JM, McPartlin JM, Fernandez-Ballart JD. The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study. Am J Clin Nutr. 2002;76:614-9.
54. Ginde AA, Sullivan AF, Mansbach JM, Camargo CA. Vitamin D insufficiency in pregnant and nonpregnant women of childbearing age in the United States. Am J Obstet Gynecol. 2010;202:436.e1-8.
55. Milman N, Hvas A-M, Bergholt T. Vitamin D status during normal pregnancy and postpartum: a longitudinal study in 141 Danish women. J Perinat Med. 2011;40:57-61.
56. Bodnar LM, Simhan HN, Powers RW, Frank MP, Cooperstein E, Roberts JM. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J Nutr. 2007;137:447-52.
57. Dati F, Schumann G, Thomas L, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP reference material (CRM 470). Eur J Clin Chem Clin Biochem. 1996;34:517-20.
58. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139:137-47.